{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-049956","form_type":"8-K","ticker":null,"cik":"0001551693","company_name":"PROJECT SAGE OLDCO, INC.","filed_at":"2024-04-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.928599+00:00","generated_at":"2026-06-03T05:32:40.691774+00:00","sec_items":["1.01","2.01","8.01"],"event_type":"m_and_a","sentiment":"negative","materiality_score":0.95,"calibrated_materiality_score":0.95,"confidence":"high","headline":"Sientra completes sale of substantially all assets to Tiger Aesthetics for $42.5M","bullets":["Completed sale of substantially all assets to Tiger Aesthetics Medical for $42.5M on April 24, 2024.","Bankruptcy Court approved the sale on April 11, 2024; Biocorneum products excluded from sale.","Company warns equity holders likely face significant or complete loss given Chapter 11 outcome.","Amended APA extended outside date from April 17 to April 24 under certain conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-049956","json":"https://secwatch.observer/filing/0000950170-24-049956.json","markdown":"https://secwatch.observer/filing/0000950170-24-049956.md","text":"https://secwatch.observer/filing/0000950170-24-049956.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1551693/000095017024049956/0000950170-24-049956-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1551693/000095017024049956/sien-20240424.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T05:32:40.691774+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"41e95cce8231b17245ddc9c9cfc16274d700995c","claim":"PROJECT SAGE OLDCO, INC. completed a disposition involving Tiger Aesthetics Medical, LLC for $42.5 million (closed 2024-04-24).","evidence_excerpt":"the Sale Assets free and clear of all claims, liens, encumbrances and all other interests, as set forth in the Sale Order (the “ Transaction ”) for a total purchase price of $42.5 million (the “ Purchase Price ”). On April 16, 2024, Tiger and the Company entered into the First Amendment to the APA (the “ Amended APA ”), which extended the outside date to close the","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1551693/000095017024049956/0000950170-24-049956-index.htm","confidence":0.95,"family_label":"M&A Transactions","details":[{"label":"Action","value":"disposition"},{"label":"Counterparty","value":"Tiger Aesthetics Medical, LLC"},{"label":"Consideration","value":"$42.5 million"},{"label":"Closing","value":"2024-04-24"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}